Ameritas Investment Partners, Inc. Lyell Immunopharma, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.84 Billion
- Q2 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 17,114 shares of LYEL stock, worth $23,617. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,114
Previous 17,114
-0.0%
Holding current value
$23,617
Previous $38,000
36.84%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LYEL
# of Institutions
123Shares Held
145MCall Options Held
2.6KPut Options Held
7.5K-
Mwg Management Ltd. Washington, DC20.2MShares$27.8 Million31.93% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$20.8 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$20.8 Million16.63% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$18.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$18.5 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $342M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...